Form 424B2 BARCLAYS BANK PLC
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying prospectus, prospectus supplement and underlying supplement do not constitute an offer to sell these Notes, and we are not soliciting an offer to buy these Notes in any state where the offer or sale is not permitted.
Subject to Completion
Preliminary Pricing Supplement dated March 28, 2024
... (continue reading...)
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: Urdea Michael S
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 424B3 Prosper Funding LLC
Listing Report: Supplement No.
52 dated
Feb 19, 2024 to Prospectus dated
Dec 28, 2023File pursuant to Rule 424(b)(3)Registration Statement Nos. 333-257739 and 333-257739-01Prosper Funding LLCBorrower Payment Dependent NotesProsper Marketplace, Inc.PMI Management Rights
This Listing Report supplements the prospectus dated
Dec 28, 2023
and provides information about each loan request (referred to as a "listing") and series of
Borrower Payment Dependent Notes (the... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 MORGAN STANLEY
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form D/A M360 CRE INCOME FUND LP
-
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: SCHUMACHER RICHARD T
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form PRE 14A Franklin BSP Capital For: Mar 28
-
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: Pollack Kevin
-
Form 424B2 UBS AG
-
Form 144 Tarsus Pharmaceuticals, Filed by: Trevejo Jose M.
-
Form 424B2 MORGAN STANLEY
-
Form 424B3 Prosper Funding LLC
-
Form 8-K Mycotopia Therapies, For: Mar 21
-
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: PETERSON JEFFREY N
-
Form 6-K NatWest Group plc For: Mar 28
-
Form 8-K Benchmark 2024-V6 Mortga For: Mar 28
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 CITIGROUP INC
-
Form NPORT-P DFA INVESTMENT DIMENSION For: Jan 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: Mangiardi Vito J
-
Form X-17A-5 NEWPOINT REAL ESTATE For: Dec 31
-
Form 6-K GOLD FIELDS LTD For: Mar 28
-
Form 497K TRANSAMERICA FUNDS
-
Form 485BPOS PUTNAM HIGH YIELD FUND
-
Form 40-F ELDORADO GOLD CORP /FI For: Dec 31
-
Form X-17A-5 JOHNSON RICE & COMPANY For: Dec 31
-
Form D Fund II, a series of
-
Form 424B2 CITIGROUP INC
-
Form 10-D BANK 2020-BNK29 For: Mar 15
-
Form NPORT-P HARTFORD MUTUAL FUNDS For: Jan 31
-
Form 424B3 Prosper Funding LLC
-
Form NPORT-P HARTFORD MUTUAL FUNDS For: Jan 31
-
Form 4 PRESSURE BIOSCIENCES For: Mar 27 Filed by: Lazarev Alexander V
-
Form NPORT-P AB HIGH INCOME FUND INC For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P ALLIANCEBERNSTEIN NATION For: Jan 31
-
Form NPORT-P AB CORPORATE SHARES For: Jan 31
-
Form NPORT-P AB SUSTAINABLE GLOBAL For: Jan 31
-
Form NPORT-P AB CORPORATE SHARES For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB CAP FUND, INC. For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB CORPORATE SHARES For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB BOND FUND, INC. For: Jan 31
-
Form NPORT-P AB CORPORATE SHARES For: Jan 31
-
Form NPORT-P AB INSTITUTIONAL FUNDS For: Jan 31
-
Form 10-K TENAX THERAPEUTICS, INC. For: Dec 31